Background & Expertise: Principal Investigator with 30+ years of expertise in fungal bio-platforms, microbial fermentation, and bioactive compound standardization. Specialized in isolating rare strains and scaling high-yield, reproducible manufacturing processes. Problems Solved for Industry: Extrusion Degradation: Bioactives lose activity during high-temp kibble extrusion. CS604 is 100% heat-stable, retaining full bioactivity post-extrusion. Over-Immunosuppression: Solves side effects of broad immunosuppressants by selectively suppressing TNF-α (~60%) and IL-6 (~50%) while preserving mucosal IgA/IL-2. IP & Biological Risk: Heat-killed matrix eliminates strain spillover or regulatory hurdles.